HY-118093-100mg
|
MedChemexpress LLC
|
N-benzoyl-L-aspartic acid [CAS 4631-12-3]
|
|
|
|
HY-118093-25mg
|
MedChemexpress LLC
|
N-benzoyl-L-aspartic acid [CAS 4631-12-3]
|
|
|
|
HY-118093-50mg
|
MedChemexpress LLC
|
N-benzoyl-L-aspartic acid [CAS 4631-12-3]
|
|
|
|
HY-118093-500mg
|
MedChemexpress LLC
|
N-benzoyl-L-aspartic acid [CAS 4631-12-3]
|
|
|
|
HY-W142140A-100mg
|
MedChemexpress LLC
|
N-Methyl-DL-valine (hydrochloride)
|
|
Cancer-programmed cell death
|
|
HY-W142140A-50mg
|
MedChemexpress LLC
|
N-Methyl-DL-valine (hydrochloride)
|
|
Cancer-programmed cell death
|
|
HY-147309-10mg
|
MedChemexpress LLC
|
16-Azidohexadecanoic acid [CAS 112668-54-9]
|
|
|
|
HY-147309-25mg
|
MedChemexpress LLC
|
16-Azidohexadecanoic acid [CAS 112668-54-9]
|
|
|
|
HY-147309-5mg
|
MedChemexpress LLC
|
16-Azidohexadecanoic acid [CAS 112668-54-9]
|
|
|
|
HY-147309-50mg
|
MedChemexpress LLC
|
16-Azidohexadecanoic acid [CAS 112668-54-9]
|
|
|
|
HY-W406070-100mg
|
MedChemexpress LLC
|
2'-O,4'-C-Methyleneguanosine [CAS 207131-16-6]
|
|
Cancer-programmed cell death
|
|
HY-W406070-250mg
|
MedChemexpress LLC
|
2'-O,4'-C-Methyleneguanosine [CAS 207131-16-6]
|
|
Cancer-programmed cell death
|
|
HY-P70038-10ug
|
MedChemexpress LLC
|
Deoxyhypusine synthase/DHS, Human (His)
|
|
|
|
HY-P70038-50ug
|
MedChemexpress LLC
|
Deoxyhypusine synthase/DHS, Human (His)
|
|
|
|
HY-136276-10mg
|
MedChemexpress LLC
|
DMNB-caged-Serine [CAS 780009-55-4]
|
|
|
|
HY-136276-5mg
|
MedChemexpress LLC
|
DMNB-caged-Serine [CAS 780009-55-4]
|
|
|
|
HY-W145646-100mg
|
MedChemexpress LLC
|
Fmoc-L-Ser((Ac)4-Beta-D-Glc)-OH [CAS 118358-38-6]
|
|
|
|
HY-W145646-25mg
|
MedChemexpress LLC
|
Fmoc-L-Ser((Ac)4-Beta-D-Glc)-OH [CAS 118358-38-6]
|
|
|
|
HY-W145646-50mg
|
MedChemexpress LLC
|
Fmoc-L-Ser((Ac)4-Beta-D-Glc)-OH [CAS 118358-38-6]
|
|
|
|
HY-P72258-10ug
|
MedChemexpress LLC
|
Melanoma antigen preferentially/PRAME, Human (His)
|
|
|
|
HY-P72258-2ug
|
MedChemexpress LLC
|
Melanoma antigen preferentially/PRAME, Human (His)
|
|
|
|
HY-P72258-50ug
|
MedChemexpress LLC
|
Melanoma antigen preferentially/PRAME, Human (His)
|
|
|
|